Antipsychotics Increasingly Being Prescribed to Children
Period prevalence of all antipsychotic prescriptions increased 3.3 percent per year from 2000 to 2019
Diagnosis & Disease Information
No Significant Association Found for ADHD Meds, CVD Risk
Meta-analysis shows no significant associations for children, adolescents, or adults, for female patients, or for those with preexisting CVD
Benzodiazepine Exposure in Pregnancy Does Not Up Risk for ADHD, Autism
No significantly increased risk seen for ADHD or ASD with exposure to benzodiazepines during first, second, third trimester
Monarch eTNS, a Bioelectronic Medical Device for Pediatric ADHD, Now Available
The device gained FDA approval in 2019 based on data from a placebo-controlled clinical trial that included 62 children with moderate to severe ADHD.
FDA Announces Adderall Shortage as Supply Decreases
Amphetamine mixed salts are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.
In Utero Exposure to Natural Disaster Ups Child Psychopathology
Exposure to Hurricane Sandy in utero linked to increased risk for depressive disorders, anxiety disorders, attention-deficit/behavioral disorders
Dietary Intake Tied to Inattention With ADHD
Children eating fewer fruits and vegetables likely to have more severe symptoms of inattention
Nonstimulant ADHD Treatment Option Approved for Adults
The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.
Warning Letters Sent to Online Pharmacies Illegally Selling Schedule II Stimulants
The FDA urges consumers to buy prescription drugs, such as Adderall, from state-licensed US pharmacies or physicians located in the US.
Prenatal Opioid Exposure Increases Risk for Childhood ADHD
Findings also show elevated risk for ADHD with interactions between multiple substances
